Psychedelic-Assisted Therapy: Breakthrough for Whom?
Psychiatr Serv April 1, 2026 DOI: 10.1176/appi.ps.26077010 via PubMed
Summary
AI-generated from the abstractThe article critically examines the claims of a breakthrough in psychedelic-assisted therapy, questioning who benefits from these treatments. It argues that the evidence, while promising, is not universally applicable and may primarily serve certain populations, potentially overlooking broader systemic and accessibility issues. The piece calls for a more nuanced understanding of the therapy's efficacy and equity.
Study at a glance
| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Key finding | The efficacy and accessibility of psychedelic-assisted therapy may be limited to specific populations, challenging the notion of a universal breakthrough. |
Abstract
Psychedelic-Assisted Therapy: Breakthrough for Whom?